ArticleDiabetes, obesity & metabolism2026

Combining Sodium-Glucose Co-Transporter-2 Inhibitor Plus Glucagon-Like Peptide-1 Receptor Agonist for Glucose-Lowering in Type 2 Diabetes: Effects of Drug Initiation Sequence on Kidney Function in Real-World Clinical Practice (CombiKid Study).

William Hinton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.